List of Excipients in API DOLUTEGRAVIR SODIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DOLUTEGRAVIR SODIUM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ViiV Healthcare Company | TIVICAY PD | dolutegravir sodium | 49702-255 | CALCIUM SULFATE DIHYDRATE | 2030-06-08 |
| ViiV Healthcare Company | TIVICAY PD | dolutegravir sodium | 49702-255 | CELLULOSE, MICROCRYSTALLINE | 2030-06-08 |
| ViiV Healthcare Company | TIVICAY PD | dolutegravir sodium | 49702-255 | CROSPOVIDONE | 2030-06-08 |
| ViiV Healthcare Company | TIVICAY PD | dolutegravir sodium | 49702-255 | HYPROMELLOSE | 2030-06-08 |
| ViiV Healthcare Company | TIVICAY PD | dolutegravir sodium | 49702-255 | MANNITOL | 2030-06-08 |
| ViiV Healthcare Company | TIVICAY PD | dolutegravir sodium | 49702-255 | POLYETHYLENE GLYCOL | 2030-06-08 |
| ViiV Healthcare Company | TIVICAY PD | dolutegravir sodium | 49702-255 | POVIDONE K30 | 2030-06-08 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for DOLUTEGRAVIR SODIUM
Excipient focus: CALCIUM SULFATE DIHYDRATE
DOLUTEGRAVIR SODIUM drug variants containing CALCIUM SULFATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing CALCIUM SULFATE DIHYDRATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
DOLUTEGRAVIR SODIUM drug variants containing CELLULOSE, MICROCRYSTALLINE
DOLUTEGRAVIR SODIUM drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
DOLUTEGRAVIR SODIUM drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
DOLUTEGRAVIR SODIUM drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE YELLOW
DOLUTEGRAVIR SODIUM drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | dolutegravir sodium | 53002-1810 |
| DOH CENTRAL PHARMACY | dolutegravir sodium | 53808-1130 |
| RedPharm Drug Inc | dolutegravir sodium | 67296-1818 |
| REMEDYREPACK INC | dolutegravir sodium | 70518-1487 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
DOLUTEGRAVIR SODIUM drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing HYPROMELLOSE
Excipient focus: LACTOSE MONOHYDRATE
DOLUTEGRAVIR SODIUM drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
DOLUTEGRAVIR SODIUM drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
DOLUTEGRAVIR SODIUM drug variants containing MANNITOL
DOLUTEGRAVIR SODIUM drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
DOLUTEGRAVIR SODIUM drug variants containing POLYETHYLENE GLYCOL
DOLUTEGRAVIR SODIUM drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
DOLUTEGRAVIR SODIUM drug variants containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing POLYSORBATE 20
Excipient focus: POLYVINYL ALCOHOL
DOLUTEGRAVIR SODIUM drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | dolutegravir sodium | 53002-1810 |
| DOH CENTRAL PHARMACY | dolutegravir sodium | 53808-1130 |
| RedPharm Drug Inc | dolutegravir sodium | 67296-1818 |
| REMEDYREPACK INC | dolutegravir sodium | 70518-1487 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
DOLUTEGRAVIR SODIUM drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | dolutegravir sodium | 53002-1810 |
| DOH CENTRAL PHARMACY | dolutegravir sodium | 53808-1130 |
| RedPharm Drug Inc | dolutegravir sodium | 67296-1818 |
| REMEDYREPACK INC | dolutegravir sodium | 70518-1487 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
DOLUTEGRAVIR SODIUM drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | dolutegravir sodium | 53002-1810 |
| DOH CENTRAL PHARMACY | dolutegravir sodium | 53808-1130 |
| RedPharm Drug Inc | dolutegravir sodium | 67296-1818 |
| REMEDYREPACK INC | dolutegravir sodium | 70518-1487 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
DOLUTEGRAVIR SODIUM drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
DOLUTEGRAVIR SODIUM drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
DOLUTEGRAVIR SODIUM drug variants containing SODIUM STEARYL FUMARATE
DOLUTEGRAVIR SODIUM drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
DOLUTEGRAVIR SODIUM drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing SUCRALOSE
Excipient focus: TALC
DOLUTEGRAVIR SODIUM drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | dolutegravir sodium | 53002-1810 |
| DOH CENTRAL PHARMACY | dolutegravir sodium | 53808-1130 |
| RedPharm Drug Inc | dolutegravir sodium | 67296-1818 |
| REMEDYREPACK INC | dolutegravir sodium | 70518-1487 |
| >Company | >Ingredient | >NDC |
DOLUTEGRAVIR SODIUM drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium | 49702-255 |
| ViiV Healthcare Company | dolutegravir sodium and lamivudine | 49702-246 |
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
DOLUTEGRAVIR SODIUM drug variants containing TITANIUM DIOXIDE
DOLUTEGRAVIR SODIUM drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ViiV Healthcare Company | dolutegravir sodium and rilpivirine hydrochloride | 49702-242 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
